GlassScriptPhysician profile
Terri L Steddum
NPI 1093905614
$4,726.18
in general payments reported to CMS, 2019-2025
16 companies · $630 in 2025
The $630 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $295 · 2021: $799 · 2022: $1,371 · 2023: $755 · 2024: $651 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,034.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,547.72 | 2020-2025 | Istent Infinite, Idosetr, Photrexa Viscous and Photrexa |
| Johnson & Johnson Vision Care, INC. | $706.05 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $551.23 | 2022-2025 | Infuse, Infuse Multifocal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $420.41 | 2019-2021 | |
| New World Medical,INC. | $313.17 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Clearpath |
| Eyevance Pharmaceuticals LLC | $226.39 | 2021-2022 | |
| Rxsight INC | $211.65 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Kala Pharmaceuticals, INC. | $120.36 | 2021 | |
| Shire North American Group INC | $118.16 | 2019 | |
| The Cameron-Ehlen Group, INC. | $117.90 | 2020 | |
| Sun Pharmaceutical Industries INC. | $114.07 | 2022 | |
| Allergan, INC. | $105.67 | 2022 | |
| Coopervision INC. | $70.52 | 2023 | Myday Contact Lens |
| Abbvie INC. | $46.84 | 2022-2023 | Lumigan |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Steddum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.